Among CKD-modeled mice, myostatin, Atrogin-1, and MuRF-1 demonstrated a pronounced upregulation in the gastrocnemius muscle, compared to those of non-CKD mice (p < 0.001) (Figure 3A). Here, FBXO32 is linked to chronic kidney disease.